发明授权
- 专利标题： N1/N2-lactam acetyl-CoA carboxylase inhibitors
- 专利标题（中）： N1 / N2-内酰胺乙酰辅酶A羧化酶抑制剂
-
申请号： US13282964申请日： 2011-10-27
-
公开(公告)号： US08859773B2公开(公告)日： 2014-10-14
- 发明人: David A. Griffith , Robert L. Dow , Scott W. Bagley , Aaron Smith
- 申请人： David A. Griffith , Robert L. Dow , Scott W. Bagley , Aaron Smith
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 代理商 James T. Wasicak
- 主分类号： C07D471/20
- IPC分类号： C07D471/20 ; C07D519/00 ; A61K31/4725
摘要：
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
公开/授权文献
- US20120108619A1 N1/N2-LACTAM ACETYL-COA CARBOXYLASE INHIBITORS 公开/授权日：2012-05-03
信息查询
